Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_46212 | 169 | 3.51 | Mlig455_014696, Mlig455_014739 | Neo: - Age: - |
FAIM | Mlig455_014696 {REF} {Length: 1218} {TRANSSPLICED} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=184.7]} {Human: ENSG00000158234, FAIM, Fas apoptotic inhibitory molecule, [Score=156, Expect=7e-48]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=155, Expect=2e-47]} {Dmel: FBgn0033985, CG10257, [Score=104, Expect=1e-27]} {Celegans: WBGene00016633, C44B11.1, [Score=143, Expect=5e-43]} {Smed: dd_Smed_v6_9854_0_1, dd_Smed_v6_9854_0_1, [Score=127, Expect=1e-36]} {RNA1509_37986} {RNA1310_24319} {RNA815_17408.1} Mlig455_014739 {REF} {Length: 976} {TRANSSPLICED} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=184.7]} {Human: ENSG00000158234, FAIM, Fas apoptotic inhibitory molecule, [Score=156, Expect=7e-48]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=155, Expect=2e-47]} {Dmel: FBgn0033985, CG10257, [Score=104, Expect=1e-27]} {Celegans: WBGene00016633, C44B11.1, [Score=143, Expect=5e-43]} {Smed: dd_Smed_v6_9854_0_1, dd_Smed_v6_9854_0_1, [Score=127, Expect=1e-36]} {RNA1509_37986} {RNA1310_24319} {RNA815_17408.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.506 | 2.513 | 0.99969 | 1.00000 | |
RegionR2 | 2.243 | 2.513 | 0.06019 | 0.29548 | |
RegionR3 | 1.202 | 2.513 | 0.27336 | 0.81750 | |
RegionR4 | 0.613 | 2.513 | 0.54298 | 0.86499 | |
RegionR5 | 0.583 | 2.513 | 0.53819 | 0.90114 | |
RegionR6 | 1.639 | 2.513 | 0.12680 | 0.64553 | |
RegionR7 | 2.937 | 2.513 | 0.00397 | 0.09342 | |
RegionR8 | -4.711 | 2.513 | 0.99955 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.113 | 2.513 | 0.99999 | 1.00000 | |
RegenerationR2 | 0.216 | 2.513 | 0.72014 | 0.96301 | |
RegenerationR3 | 1.115 | 2.513 | 0.14100 | 0.56713 | |
RegenerationR4 | 0.404 | 2.513 | 0.61307 | 0.91804 | |
RegenerationR5 | 0.006 | 2.513 | 0.99418 | 1.00000 | |
RegenerationR6 | -0.018 | 2.513 | 0.98110 | 1.00000 | |
RegenerationBL | 1.623 | 2.513 | 0.26339 | 0.62174 | |
RegenerationTP | 1.429 | 2.513 | 0.48808 | 0.89402 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_46212 | 169 | 3.51 | Mlig455_014696, Mlig455_014739 | Neo: - Age: - |
FAIM | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_014696 {REF} {Length: 1218} {TRANSSPLICED} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=184.7]} {Human: ENSG00000158234, FAIM, Fas apoptotic inhibitory molecule, [Score=156, Expect=7e-48]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=155, Expect=2e-47]} {Dmel: FBgn0033985, CG10257, [Score=104, Expect=1e-27]} {Celegans: WBGene00016633, C44B11.1, [Score=143, Expect=5e-43]} {Smed: dd_Smed_v6_9854_0_1, dd_Smed_v6_9854_0_1, [Score=127, Expect=1e-36]} {RNA1509_37986} {RNA1310_24319} {RNA815_17408.1} Mlig455_014739 {REF} {Length: 976} {TRANSSPLICED} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=184.7]} {Human: ENSG00000158234, FAIM, Fas apoptotic inhibitory molecule, [Score=156, Expect=7e-48]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=155, Expect=2e-47]} {Dmel: FBgn0033985, CG10257, [Score=104, Expect=1e-27]} {Celegans: WBGene00016633, C44B11.1, [Score=143, Expect=5e-43]} {Smed: dd_Smed_v6_9854_0_1, dd_Smed_v6_9854_0_1, [Score=127, Expect=1e-36]} {RNA1509_37986} {RNA1310_24319} {RNA815_17408.1} |
2. | MligTC455_54209 | 196 | 4.09 | Mlig455_005246 | Neo: - Age: logFC(26M/2M)=-0.457 |
LRRC74A | 1.705 | - | - | 0.954 | - | - | 0.751 | Mlig455_005246 {REF} {Length: 4154} {Pfam: Leucine Rich repeat [PF13516.8, score=97.2]; Leucine Rich Repeat [PF00560.35, score=29.2]; Leucine Rich repeats (2 copies) [PF12799.9, score=22.2]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=186, Expect=2e-51]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=182, Expect=4e-50]} {Celegans: WBGene00009201, F28C1.3, Protein phosphatase 1 regulatory subunit 37 homolog, [Score=80.1, Expect=2e-15]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [RH, Score=369, Expect=3e-120]} {RNA1509_14523, RNA1509_24088} {RNA1310_10119, RNA1509_14523, RNA1509_24088} {RNA1509_14523, RNA1509_24088, RNA815_985} |
3. | MligTC455_51407 | 56 | 1.17 | Mlig455_048221 | Neo: - Age: - |
1.697 | - | - | 0.955 | 0.742 | - | - | Mlig455_048221 {REF} {Length: 2079} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=63.5, Expect=9e-13]} {RNA1509_36146} {RNA1310_40326.1} {RNA815_35436} | |
4. | MligTC455_38920 | 270 | 5.63 | Mlig455_021507 | Neo: - Age: logFC(26M/2M)=-0.385 |
SPAG17 | 0.973 | - | - | - | - | - | 0.973 | Mlig455_021507 {REF} {Length: 5062} {Pfam: Flagellar-associated PapD-like [PF14874.8, score=44.6]} {Human: ENSG00000155761, SPAG17, sperm associated antigen 17, [RH, Score=456, Expect=2e-132]} {Mouse: ENSMUSG00000027867, Spag17, sperm associated antigen 17, [Score=189, Expect=9e-48]} {Smed: dd_Smed_v6_9301_0_1, dd_Smed_v6_9301_0_1, [Score=507, Expect=4e-150]} {RNA1509_22687} {RNA1310_263.1} {RNA815_2815.1} |
5. | MligTC455_02525 | 62 | 1.3 | Mlig455_022855, Mlig455_032660, Mlig455_032663 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.700/0.03365 |
NYNRIN | 0.968 | - | - | - | - | 0.968 | - | Mlig455_022855 {REF} {Length: 614} {Pfam: Integrase zinc binding domain [PF17921.3, score=32.4]} {RNA1509_57193} {RNA1310_16877} Mlig455_032660 {REF} {Length: 2538} {Pfam: Integrase core domain [PF00665.28, score=56.5]; Integrase zinc binding domain [PF17921.3, score=51.2]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=50.4, Expect=7e-06]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=111, Expect=5e-27]} {RNA1509_57193} {RNA1310_16877} {RNA815_54861} Mlig455_032663 {REF} {Length: 2541} {Pfam: Integrase core domain [PF00665.28, score=56.5]; Integrase zinc binding domain [PF17921.3, score=51.2]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=50.4, Expect=7e-06]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=48.9, Expect=1e-05]} {Smed: dd_Smed_v6_20599_0_1, dd_Smed_v6_20599_0_1, [Score=112, Expect=4e-27]} {RNA1509_57193} {RNA1310_16877, RNA1509_57193} {RNA1509_57193, RNA815_54861} |
6. | MligTC455_13403 | 157 | 3.27 | Mlig455_058321 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.878/0.03174 |
LARP1 | 0.965 | - | - | 0.965 | - | - | - | Mlig455_058321 {REF} {Length: 2328} {Human: ENSG00000155506, LARP1, La ribonucleoprotein domain family member 1, [Score=178, Expect=6e-52]} {Mouse: ENSMUSG00000037331, Larp1, La ribonucleoprotein domain family, member 1, [Score=178, Expect=5e-52]; ENSMUSG00000025762, Larp1b, La ribonucleoprotein domain family, member 1B, [Score=171, Expect=9e-54]} {Dmel: FBgn0261618, larp, La related protein, [Score=172, Expect=4e-50]} {Celegans: WBGene00020097, larp-1, La-related protein 1, [Score=136, Expect=2e-37]} {Smed: dd_Smed_v6_2667_0_1, dd_Smed_v6_2667_0_1, [Score=170, Expect=2e-49]} {RNA1509_29509} {RNA1310_3597.2, RNA1509_29509} {RNA1509_29509, RNA815_2607} |
7. | MligTC455_17475 | 56 | 1.16 | Mlig455_065300, Mlig455_065322 | Neo: - Age: - |
MYT1L | 0.959 | - | - | 0.959 | - | - | - | Mlig455_065300 {REF} {Length: 3149} {Pfam: Zinc finger, C2HC type [PF01530.20, score=77.6]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=130, Expect=2e-33]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=126, Expect=1e-29]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=1e-29]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=6e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=7e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=125, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.4, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=123, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=132, Expect=7e-35]} {RNA1310_120779} Mlig455_065322 {REF} {Length: 1854} {Pfam: Zinc finger, C2HC type [PF01530.20, score=74.9]} {Human: ENSG00000186487, MYT1L, myelin transcription factor 1 like, [RH, Score=129, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=126, Expect=3e-30]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=125, Expect=8e-30]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=128, Expect=7e-31]; ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=125, Expect=6e-30]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=124, Expect=1e-29]} {Dmel: FBgn0263772, CG43689, [Score=87.0, Expect=1e-17]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=124, Expect=2e-30]} {Smed: dd_Smed_v6_80183_0_1, dd_Smed_v6_80183_0_1, [RH, Score=133, Expect=3e-35]} {RNA1310_120779} |
8. | MligTC455_42020 | 58 | 1.22 | Mlig455_059333 | Neo: - Age: - |
WSCD2 | 0.959 | - | - | 0.959 | - | - | - | Mlig455_059333 {REF} {Length: 1392} {Pfam: WSC domain [PF01822.21, score=60.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=48.9, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=48.5, Expect=1e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.5, Expect=9e-11]} {RNA1509_57286} {RNA1310_34378} {RNA815_35918} |
9. | MligTC455_49878 | 31 | 0.65 | Mlig455_050656 | Neo: - Age: - |
CHRNA10 | 0.958 | - | - | 0.958 | - | - | - | Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952} |
10. | MligTC455_38031 | 24 | 0.5 | Mlig455_049070 | Neo: - Age: - |
0.957 | - | - | 0.957 | - | - | - | Mlig455_049070 {REF} {Length: 2566} {RNA1310_26848} {RNA815_42675} | |
11. | MligTC455_17412 | 44 | 0.91 | Mlig455_069737 | Neo: - Age: - Region-enriched R2: 5.062/0.00923 |
0.956 | - | - | 0.956 | - | - | - | Mlig455_069737 {REF} {Length: 1628} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=42.8]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=3e-14]} {RNA1310_45758} {RNA815_42912} | |
12. | MligTC455_45064 | 98 | 2.04 | Mlig455_059206 | Neo: - Age: - Region-enriched R2: 3.378/0.01843 |
MTUS2 | 0.956 | - | - | 0.956 | - | - | - | Mlig455_059206 {REF} {Length: 4973} {Human: ENSG00000132938, MTUS2, microtubule associated scaffold protein 2, [RH, Score=70.5, Expect=1e-11]} {Mouse: ENSMUSG00000029651, Mtus2, microtubule associated tumor suppressor candidate 2, [RH, Score=72.0, Expect=3e-12]} {Dmel: FBgn0015600, toc, toucan, [RH, Score=58.5, Expect=3e-08]} {RNA1509_44985, RNA1509_58911} {RNA1310_13922.1, RNA1509_44985} {RNA1509_44985, RNA815_11784} |
13. | MligTC455_53111 | 32 | 0.68 | Mlig455_014472 | Neo: - Age: - |
0.955 | - | - | 0.955 | - | - | - | Mlig455_014472 {REF} {Length: 2012} {TRANSSPLICED} {RNA1310_65341} | |
14. | MligTC455_30299 | 190 | 3.96 | Mlig455_066329 | Neo: - Age: logFC(26M/2M)=0.517 |
0.953 | - | - | 0.953 | - | - | - | Mlig455_066329 {REF} {Length: 4376} {Pfam: Tetratricopeptide repeat [PF13424.8, score=68.7]; Tetratricopeptide repeat [PF13181.8, score=34.9]; Tetratricopeptide repeat [PF13374.8, score=23.9]; Tetratricopeptide repeat [PF07719.19, score=23.2]; Tetratricopeptide repeat [PF14559.8, score=23.0]} {Smed: dd_Smed_v6_6239_0_1, dd_Smed_v6_6239_0_1, [Score=48.9, Expect=7e-06]} {RNA1509_11012} {RNA1310_2274} {RNA815_1508.1} | |
15. | MligTC455_13282 | 95 | 1.99 | Mlig455_021294 | Neo: - Age: Down-Up-Down |
0.952 | - | - | 0.952 | - | - | - | Mlig455_021294 {REF} {Length: 840} {NoTransDecoderORF} {RNA1310_63724} {RNA815_38056} | |
16. | MligTC455_15720 | 37 | 0.78 | Mlig455_000177 | Neo: - Age: Up-Down-Down |
TRPC3 | 0.951 | - | - | 0.951 | - | - | - | Mlig455_000177 {REF} {Length: 4780} {Pfam: Transient receptor ion channel II [PF08344.13, score=91.7]; Ion transport protein [PF00520.33, score=56.1]; Ankyrin repeats (3 copies) [PF12796.9, score=34.0]; Ankyrin repeat [PF13606.8, score=29.0]; Ankyrin repeat [PF00023.32, score=24.2]} {Human: ENSG00000138741, TRPC3, transient receptor potential cation channel subfamily C member 3, [Score=517, Expect=2e-166]; ENSG00000137672, TRPC6, transient receptor potential cation channel subfamily C member 6, [Score=506, Expect=2e-162]; ENSG00000069018, TRPC7, transient receptor potential cation channel subfamily C member 7, [Score=506, Expect=4e-163]} {Mouse: ENSMUSG00000027716, Trpc3, transient receptor potential cation channel, subfamily C, member 3, [Score=511, Expect=2e-164]; ENSMUSG00000021541, Trpc7, transient receptor potential cation channel, subfamily C, member 7, [Score=507, Expect=2e-163]; ENSMUSG00000031997, Trpc6, transient receptor potential cation channel, subfamily C, member 6, [Score=501, Expect=1e-160]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=451, Expect=1e-139]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [Score=448, Expect=9e-140]} {Smed: dd_Smed_v6_13048_0_2, dd_Smed_v6_13048_0_2, [RH, Score=1276, Expect=0.0]} {RNA1509_39636} {RNA1310_5314} {RNA815_4923} |
17. | MligTC455_21693 | 48 | 1 | Mlig455_024307, Mlig455_024362, Mlig455_024476 | Neo: - Age: - |
AHR | 0.951 | - | - | 0.951 | - | - | - | Mlig455_024307 {REF} {Length: 4440} {Pfam: PAS fold [PF08447.14, score=59.6]; PAS fold [PF00989.27, score=42.5]; PAS domain [PF14598.8, score=40.5]; PAS domain [PF13426.9, score=18.9]; C-terminal region of eIF3h [PF19445.1, score=18.6]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=229, Expect=8e-64]; ENSG00000283321, AC019117.2, novel protein, [Score=228, Expect=1e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=216, Expect=2e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=7e-91]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=200, Expect=8e-56]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=369, Expect=4e-118]} {RNA1310_45588} Mlig455_024362 {REF} {Length: 4404} {Pfam: PAS fold [PF08447.14, score=59.5]; PAS fold [PF00989.27, score=43.6]; PAS domain [PF14598.8, score=41.4]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.4]; C-terminal region of eIF3h [PF19445.1, score=20.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [RH, Score=298, Expect=1e-88]; ENSG00000283321, AC019117.2, novel protein, [RH, Score=297, Expect=2e-88]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [RH, Score=286, Expect=2e-84]} {Dmel: FBgn0003513, ss, spineless, [RH, Score=398, Expect=1e-124]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [RH, Score=265, Expect=6e-79]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [RH, Score=503, Expect=4e-169]} {RNA1310_45588} Mlig455_024476 {REF} {Length: 4767} {Pfam: PAS fold [PF08447.14, score=58.8]; PAS fold [PF00989.27, score=41.6]; PAS domain [PF14598.8, score=40.1]; Helix-loop-helix DNA-binding domain [PF00010.28, score=27.1]} {Human: ENSG00000106546, AHR, aryl hydrocarbon receptor, [Score=230, Expect=4e-63]; ENSG00000283321, AC019117.2, novel protein, [Score=229, Expect=4e-63]} {Mouse: ENSMUSG00000019256, Ahr, aryl-hydrocarbon receptor, [Score=217, Expect=8e-59]} {Dmel: FBgn0003513, ss, spineless, [Score=303, Expect=5e-89]} {Celegans: WBGene00000096, ahr-1, Aryl hydrocarbon receptor protein 1, [Score=199, Expect=1e-54]} {Smed: dd_Smed_v6_17534_0_1, dd_Smed_v6_17534_0_1, [Score=373, Expect=3e-117]} {RNA1310_45588} |